Tryton Medical Announces First Results From Pivotal Study of the Tryton Side Branch Stent™ Presented at TCT 2013 Annual Meeting in Late Breaking Clincial Trial Session

Dateline City: SAN FRANCISCO SAN FRANCISCO–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, today announced the first results from the Tryton Side Branch Stent Pivotal IDE trial were presented during a Late Breaking Clinical Trial session at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. The Tryton Pivotal IDE trial is an international, …

Global Bifurcation Leader Tryton Medical Announces Events at TCT 2013

Dateline City: SAN FRANCISCO First Results from the Tryton Side Branch Stent Pivotal IDE Trial Will Be Presented Wednesday, October 30 in a Late Breaking Clinical Trial Session SAN FRANCISCO–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, today announced activities highlighting the latest data and experience with the Tryton Side Branch Stent at the …

Tryton Medical Introduces Physician Education Program

Dateline City: DURHAM, N.C. DURHAM, N.C.–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, today announced it has introduced a physician education program, starting with the Tryton Bifurcation Case of the Month. The Tryton Bifurcation Case of the Month series highlights physician review and analysis of a patient case that employed dedicated bifurcation stenting. The …